Servatus Limited, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, ...
The Monash University Faculty of Engineering has launched a new world-class robotics research facility to train the next...
Australian researchers are developing a 3D printed bracelet to allow people living with hand-impairment to easily use co...
Varian, a Siemens Healthineers company (Varian), has announced a five-year research and professional services agreement ...
The Therapeutic Goods Administration (TGA), part of the Department of Health in Australia, has granted a provisiona...
Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerativ...
Australia's Anteris Technologies has announced its research partnership with Yale University and the Yale Cardiova...
HealthBeats, a Singapore-based healthtech startup with end-to-end remote vitals monitoring solution, has announced the c...
China's Antengene Corporation, a leading innovative, commercial-stage global biopharmaceutical company dedicated to disc...
Fostering global excellence in diagnostic accuracy, Australia-based DetectedX and GE Healthcare have entered into an edu...
More than $4 million has been awarded to two projects at The George Institute for Global Health at UNSW Sydney, Australi...
Australia's SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has added saliva to the list of ...
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has bee...
A skin microbiopsy device developed by researchers at The University of Queensland (UQ) in Australia, that takes tissue ...
Researchers from the University of Sydney and Westmead Hospital in Australia have been awarded $1.8 million to advance r...
Australia's Telix Pharmaceuticals has announced first commercial doses of its prostate cancer imaging agent, Illuccix&re...
Almost two thirds of acute stroke patients fail to survive more than a decade and have high risk of recurrence, promptin...
Australia's Paradigm Biopharmaceuticals, a clinical stage biopharmaceutical company focused on repurposing existing...
